Journal List > Korean J Gastroenterol > v.55(3) > 1006646

TOOLS
Park and Han: Is Clostridium difficile Infection Increasing in Korea?
Editorial

Korean J Gastroenterol 2010;55(3):208-210.

Published online: 21 February 2010

DOI: https://doi.org/10.4166/kjg.2010.55.3.208

Is Clostridium difficile Infection Increasing in Korea?

Hye Sun Park, M.D., Dong Soo Han, M.D.

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea

Correspondence to: Dong Soo Han, M.D. Division of Gastroenterology, Hanyang University Guri Hospital, 249-1, Gyomun-dong, Guri 471-701, Korea Tel: +82-31-560-2226, Fax: +82-31-555-2998 E-mail: hands@hanyang.ac.kr

Copyright © 2010 The Korean Journal of Gastroenterology

REFERENCES

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotics associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978; 298:531–534.
2. Ricciardi R, Rothenbeger DA, Mandoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007; 142:624–631.
3. Pé pin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMA J. 2005; 173:1037–1042.
4. Kuijper EJ, van Dissel JT, Wilcox MH. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis. 2007; 20:376–383.
5. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008; 62:388–396.
6. Tae CH, Jung SA, Song HJ, et al. The first case of anti-biotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci. 2009; 24:520–524.
7. Lee YJ, Choi MG, Lim CH, et al. Change of Clostridium difficile colitis during recent 10 years in Korea. Korean J Gastroenterol. 2010; 55:169–174.
8. Lee JH, Lee SY, Kim YS, et al. The incidence and clinical features of Clostridium difficile-infection; single center study. Korean J Gastroenterol. 2010; 55:175–182.
9. Byun TJ, Han DS, Ahn SB, et al. Clinical characteristics and changing epidemiology of Clostiridium difficile-associated dia-sease (CDAD). Korean J Gastroenterol. 2009; 54:13–19.
10. Monaghan T, Boswell T, Mahida YR. Recent advances in Clostridium difficile-associated disease. Gut. 2008; 57:850–860.
11. Park HS, Han DS. Management of antibiotics-associated diarrhea. Korean J Gastroenterol. 2009; 54:5–12.
crossref
12. Leffler DA, Lamont JT. Treatment of Clostridium difficile-associated disease. Gastroenterology. 2009; 136:1899–1912.
13. Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin infect Dis. 2008; 46(suppl 1):S32–42.
14. Surawicz CM. Reining in recurrent Clostridium difficile infection–who's at risk? Gastroenterology. 2009; 136:1152–1154.
TOOLS
Similar articles